Want to join the conversation?
$DGX's net cash used in investing activities for 2015 decreased to $362MM from $1Bil in the previous year. The decline was a result of fall in business acquisitions and a decrease in capital expenditures, which were partially offset by cash included in its Clinical Trials Contribution.
$AAL is getting stronger into Dec. after a strong Nov..!! I’m feeling confident about their 4Q revenue forecast for a margin rise.
$KO’s CEO Muhtar Kent to step down next year. COO James Quincey will take the helm in what is already a smooth sailing scenario. And as always, shares reflect by growing 2% after the market opened.